Hearing loss, which may be due to many different causes, is generally of two types: conductive and sensorineural. Sensorineural hearing loss is due to the absence or destruction of the hair cells in the cochlea that transduce sound signals into nerve impulses. Various hearing prostheses are commercially available to provide individuals suffering from sensorineural hearing loss with the ability to perceive sound. For example, cochlear implants use an electrode array implanted in the cochlea of a recipient to bypass the mechanisms of the ear. More specifically, an electrical stimulus is provided via the electrode array to the auditory nerve, thereby causing a hearing percept.
Conductive hearing loss occurs when the normal mechanical pathways that provide sound to hair cells in the cochlea are impeded, for example, by damage to the ossicular chain or the ear canal. Individuals suffering from conductive hearing loss may retain some form of residual hearing because the hair cells in the cochlea may remain undamaged.
Individuals suffering from conductive hearing loss typically receive an acoustic hearing aid. Hearing aids rely on principles of air conduction to transmit acoustic signals to the cochlea. In particular, a hearing aid typically uses an arrangement positioned in the recipient's ear canal or on the outer ear to amplify a sound received by the outer ear of the recipient. This amplified sound reaches the cochlea causing motion of the perilymph and stimulation of the auditory nerve.
In contrast to hearing aids, which rely primarily on the principles of air conduction, certain types of hearing prostheses commonly referred to as bone conduction devices, convert a received sound into vibrations. The vibrations are transferred through the skull to the cochlea causing generation of nerve impulses, which result in the perception of the received sound. Bone conduction devices are suitable to treat a variety of types of hearing loss and may be suitable for individuals who cannot derive sufficient benefit from acoustic hearing aids, cochlear implants, etc., or for individuals who suffer from stuttering problems. Conversely, cochlear implants can have utilitarian value with respect to recipients where all of the inner hair inside the cochlea has been damaged or otherwise destroyed. Electrical impulses are provided to electrodes located inside the cochlea, which stimulate nerves of the recipient so as to evoke a hearing percept.
In accordance with one aspect, there is an external component of a prosthesis, comprising a first module including a functional component and first structure including magnetic material, wherein the first module is configured to be retained against skin of a recipient via a magnetic field at least partially generated by a permanent magnet implanted in a recipient that interacts with the magnetic material of the first structure, the first module including a skin interfacing surface configured to interact with skin of the recipient when the first module is retained against the skin of the recipient; and a second module including a second structure including magnetic material configured to enhance magnetic retention of the external component to skin of a recipient, wherein the second module is removably attached to the first module and visible from an outside of the external component when the second module is attached to the first module and when viewed from a side opposite the skin interfacing side.
In another exemplary embodiment, there is a button sound processor, comprising a first component including a first permanent magnet; and a second component including soft magnetic material, wherein the second component is configured to direct a magnetic flux at least partially generated by the first permanent magnet differently from that which would exist in the absence of the second component via the soft magnetic material.
In accordance with another aspect, there is a method, comprising: obtaining a first portion of a headpiece for a prosthesis, the first portion including electronic components of the prosthesis and a first permanent magnet; obtaining a second portion of the headpiece, the second portion including a magnetic material; attaching the second portion to the first portion; and attaching the combined first and second portions to a recipient having implanted therein a second permanent magnet such that the first portion and the second portion are magnetically retained to the skin of the recipient via interaction with the magnetic field generated by the second permanent magnet and component(s) of the headpiece, wherein the magnetic material alters the magnetic flux established by the second permanent magnet such that the magnetic flux is widened about a longitudinal axis between the second permanent magnet and the first portion relative to that which would be the case in the absence of the second portion.
In accordance with another aspect, there is a body piece configured for transcutaneous communication with an implanted component implanted in a recipient, comprising: an inductance coil; a first permanent magnet; and a second permanent magnet, wherein the first permanent magnet has a north-south polarity that is parallel to a longitudinal axis of the body piece, the second permanent magnet has a north-south polarity at an oblique angle relative to the north-south polarity of the first permanent magnet, and the body piece is configured such that the second permanent magnet is readily removably connected at least indirectly to the first permanent magnet.
Some embodiments are described below with reference to the attached drawings, in which:
Embodiments herein are described primarily in terms of a bone conduction device, such as an active transcutaneous bone conduction device. However, it is noted that the teachings detailed herein and/or variations thereof are also applicable to a cochlear implant and/or a middle ear implant. Accordingly, any disclosure herein of teachings utilized with a bone conduction device also corresponds to a disclosure of utilizing those teachings with respect to a cochlear implant and utilizing those teachings with respect to a middle ear implant. Moreover, at least some exemplary embodiments of the teachings detailed herein are also applicable to an active and/or a passive transcutaneous bone conduction device. It is further noted that the teachings detailed herein can be applicable to other types of prostheses, such as by way of example only and not by way of limitation, a retinal implant. Indeed, the teachings detailed herein can be applicable to any component that is held against the body that utilizes an RF coil and/or an inductance coil or any type of communicative coil to communicate with a component implanted in the body. That said, the teachings detailed herein will be directed by way of example only and not by way of limitation towards a component that is held against the head of a recipient for purposes of the establishment of an external component of the hearing prosthesis. In view of this,
Still, it is noted that in at least some exemplary embodiments, element 100 is instead a cochlear implant, where the RF inductance coil of the external component communicates with an RF inductance coil of the implanted component, which implanted RF inductance coil is in signal communication with a receiver/stimulator of a cochlear implant, which receiver/stimulator receives signals from the RF inductance coil and converts those signals into electrical signals applied to electrodes implanted in the cochlea to evoke a hearing percept via electrical stimulation. Note also that in at least some exemplary embodiments, element 100 is instead a so-called middle ear implant, where the RF inductance coil of the external component communicates with an RF inductance of the implanted component, which RF inductance coil is in signal communication with the receiver/stimulator of a middle ear implant. The receiver/stimulator receives signals from the RF inductance coil and converts those signals into electrical signals that are applied to an actuator to cause the actuator to actuate, and thus evoke a hearing percept via mechanical stimulation of components of the auditory system.
In a fully functional human hearing anatomy, outer ear 101 comprises an auricle 105 and an ear canal 106. A sound wave or acoustic pressure 107 is collected by auricle 105 and channeled into and through ear canal 106. Disposed across the distal end of ear canal 106 is a tympanic membrane 104 which vibrates in response to acoustic wave 107. This vibration is coupled to oval window or fenestra ovalis 210 through three bones of middle ear 102, collectively referred to as the ossicles 111 and comprising the malleus 112, the incus 113, and the stapes 114. The ossicles 111 of middle ear 102 serve to filter and amplify acoustic wave 107, causing oval window 210 to vibrate. Such vibration sets up waves of fluid motion within cochlea 139. Such fluid motion, in turn, activates hair cells (not shown) that line the inside of cochlea 139. Activation of the hair cells causes appropriate nerve impulses to be transferred through the spiral ganglion cells and auditory nerve 116 to the brain (not shown), where they are perceived as sound.
More particularly, sound input device 126 (e.g., a microphone) converts received sound signals into electrical signals. These electrical signals are processed by the sound processor. The sound processor generates control signals which cause the actuator to vibrate. In other words, the actuator converts the electrical signals into mechanical motion to impart vibrations to the recipient's skull.
Alternatively, sound input element 126 may be subcutaneously implanted in the recipient, or positioned in the recipient's ear. Sound input element 126 may also be a component that receives an electronic signal indicative of sound, such as, for example, from an external audio device. For example, sound input element 126 may receive a sound signal in the form of an electrical signal from an MP3 player electronically connected to sound input element 126.
Bone conduction device 100 comprises a sound processor (not shown), an actuator (also not shown), and/or various other operational components. In operation, the sound processor converts received sounds into electrical signals. These electrical signals are utilized by the sound processor to generate control signals that cause the actuator to vibrate. In other words, the actuator converts the electrical signals into mechanical vibrations for delivery to the recipient's skull.
In accordance with some embodiments, a fixation system 162 may be used to secure implantable component 150 to skull 136. As described below, fixation system 162 may be a bone screw fixed to skull 136, and also attached to implantable component 150.
In one arrangement of
In another arrangement of
In an exemplary embodiment, the vibrating electromagnetic actuator 342 is a device that converts electrical signals into vibration. In operation, sound input element 126 converts sound into electrical signals. Specifically, the transcutaneous bone conduction device 300 provides these electrical signals to vibrating electromagnetic actuator 342, or to a sound processor (not shown) that processes the electrical signals, and then provides those processed signals to vibrating electromagnetic actuator 342. The vibrating electromagnetic actuator 342 converts the electrical signals (processed or unprocessed) into vibrations. Because vibrating electromagnetic actuator 342 is mechanically coupled to plate 346, the vibrations are transferred from the vibrating electromagnetic actuator 342 to plate 346. Implanted plate assembly 352 is part of the implantable component 350, and is made of a ferromagnetic material that may be in the form of a permanent magnet, that generates and/or is reactive to a magnetic field, or otherwise permits the establishment of a magnetic attraction between the external device 340 and the implantable component 350 sufficient to hold the external device 340 against the skin of the recipient. Accordingly, vibrations produced by the vibrating electromagnetic actuator 342 of the external device 340 are transferred from plate 346 across the skin to plate 355 of plate assembly 352. This can be accomplished as a result of mechanical conduction of the vibrations through the skin, resulting from the external device 340 being in direct contact with the skin and/or from the magnetic field between the two plates. These vibrations are transferred without penetrating the skin with a solid object, such as an abutment, with respect to a percutaneous bone conduction device.
As may be seen, the implanted plate assembly 352 is substantially rigidly attached to a bone fixture 341 in this embodiment. Plate screw 356 is used to secure plate assembly 352 to bone fixture 341. The portions of plate screw 356 that interface with the bone fixture 341 substantially correspond to an abutment screw discussed in some additional detail below, thus permitting plate screw 356 to readily fit into an existing bone fixture used in a percutaneous bone conduction device. In an exemplary embodiment, plate screw 356 is configured so that the same tools and procedures that are used to install and/or remove an abutment screw (described below) from bone fixture 341 can be used to install and/or remove plate screw 356 from the bone fixture 341 (and thus the plate assembly 352).
External component 440 includes a sound input element 126 that converts sound into electrical signals. Specifically, the transcutaneous bone conduction device 400 provides these electrical signals to vibrating electromagnetic actuator 452, or to a sound processor (not shown) that processes the electrical signals, and then provides those processed signals to the implantable component 450 through the skin of the recipient via a magnetic inductance link. In this regard, a transmitter coil 442 of the external component 440 transmits these signals to implanted receiver coil 456 located in housing 458 of the implantable component 450. Components (not shown) in the housing 458, such as, for example, a signal generator or an implanted sound processor, then generate electrical signals to be delivered to vibrating electromagnetic actuator 452 via electrical lead assembly 460. The vibrating electromagnetic actuator 452 converts the electrical signals into vibrations.
The vibrating electromagnetic actuator 452 is mechanically coupled to the housing 454. Housing 454 and vibrating electromagnetic actuator 452 collectively form a vibratory apparatus 453. The housing 454 is substantially rigidly attached to bone fixture 341.
External component 540 comprises a first sub-component 550 and a second sub-component 560. It is briefly noted that back lines have been eliminated in some cases for purposes of ease of illustration (e.g., such as the line between sub-component 550 and sub-component 560—note that
In an exemplary embodiment, external component 540 is a so-called button sound processor as detailed above. In this regard, in the exemplary embodiment of
The external component 540 further includes a magnet 564 which is housed in sub-component 560. Sub-component 560 is removably replaceable to/from sub-component 550. In the exemplary embodiment of
Still with reference to
It is briefly noted that as used herein, the sub-component 550 is utilized as shorthand for the external component 540. That is, external component 540 exists irrespective of whether the sub-component 560 is located in the sub-component 550 or otherwise attached to sub-component 550.
In the embodiment of
The sub-component 550 comprises a housing 548 that contains the RF coil 542, the sound processor apparatus 556, and, in some embodiments, a battery.
While the embodiment of
Due to variations in skin flap thickness (the distance between a top surface of the magnet implanted in the recipient and the outer surface of the skin), there can be utilitarian value with respect to varying the strength of the magnetic field generated by the magnet(s) of the external component 540. That is, in an exemplary embodiment, all things being equal, for a greater skin flap thickness, a stronger magnetic field should be generated by the external component to obtain the same or effectively same retention forces between the external component and implantable component. This is because the retention force decreases with increasing skin flap thickness, all things being equal. In at least some exemplary embodiments, the strength of the magnetic field generated by the external component 540 is varied by the use of exchangeable magnet models. For example, the second sub-component 560 could be replaced with a new sub-component 560 that has a stronger magnet 564/the magnet 564 located within the housing 562 of the second sub-component 560 generates a stronger magnetic field. It is noted that in at least some exemplary embodiments, it is the size of the magnet that results in a greater/stronger magnetic field. In at least some exemplary embodiments of these exemplary embodiments, this size is increased by making the magnet thicker (i.e., increasing the height of the magnet in the direction of the longitudinal axis 599). Thus, the height or thickness of the button sound processor is greater than that which would otherwise be the case so as to accommodate the thicker magnet. With respect to the embodiment of
In view of the above, it can be understood that adjusting the retention force by managing features associated with the magnet 564 (thickness, position, etc.) drives a thicker (distance along the axis 599) external component than that which would otherwise be the case if a minimum thickness magnet can be utilized/the magnet need not be moved within the external component 540. According to at least some exemplary embodiments detailed herein, a thinner magnet is utilized as magnet 564 and/or the position of magnet 564 along the longitudinal axis 599 is such that the magnet is as close to the skin interfacing surface assembly 596 as possible, thus reducing and/or eliminating the impact of the magnet 564 with respect to driving the thickness of the external component. In an exemplary embodiment, the thickness and the positioning of the magnet is designed to accommodate the typical recipient. In an exemplary embodiment, the thickness and positioning of the magnet is designed to accommodate recipients where statistically lower retention force between the external component and the implantable component is needed to retain the external component to the recipient relative to other recipients. By way of example only and not by way of limitation, if a population of recipients is such that 75% have a skin flap thickness of X to Y and the remaining 25% have a skin flap thickness of Y+Z, the design of the external component vis-à-vis the magnet 564 (size and positioning) could be directed towards achieving utilitarian retention for the 75% of the population that have the skin flap thickness of X to Y, thus resulting in an external component that has a thickness that is less than that which would be the case if the design of the external component vis-à-vis the internal magnet 560 was to accommodate those of the 75 percentile and those of the remaining 25 percentile.
Note also that this concept can be extended to situations where a given percentile of a population almost never experiences accelerations above a certain level, and the remaining population sometimes experiences accelerations above a certain level. The design of the external component can be directed towards meeting the requirements of the former, thus reducing the thickness of the external component 540.
Still, such an embodiment (where the design is directed towards the population requiring a less-strong magnetic field generated by the internal magnet of the external component 540) can result in a situation where the retention force between the external component and implantable component is not as utilitarian as that which otherwise could be the case for a given population (e.g., the population having the skin flap thickness of Y+Z). Accordingly, there is utilitarian value with respect to being able to increasing the strength of the magnetic field used to hold the external component to the skin of the recipient for the “greater retention force need” populations.
The module 580 is readily attachable to the external component 540. In an exemplary embodiment, the module 580 and the external component 540 are configured such that once the module 580 is attached to the component 540, the module 580 cannot be removed. In this regard, such an embodiment can be directed towards a scenario where the external component 540 is to be customized to a given recipient, and because the external component 540 will not be used by another recipient, the customization can be achieved in a semi-permanent matter. That said, in an alternate embodiment, the module 580 is readily removable after attachments to the external component 540. In an exemplary embodiment, such can be achieved by a snap fit or an interference that between the external component 540 and the module 580. Still further, in an exemplary embodiment, the outer circumference of the external component 540 and the internal circumference of the module 580 can be threaded so that the module 580 can be screwed on to the external component 540. Any device, system, and/or method of achieving the attachment of the module 580 to the external component 540, and, in some embodiments, any device, system, and/or method of achieving the subsequent removal of the module 580 to the external component 540 (with respect to those embodiments where the module 580 is removable) can be utilized in at least some exemplary embodiments.
Briefly, it is noted that the geometries of the module 580 can be different than that depicted in
Also, while the embodiments of
In view of the above, there is an external component of a prosthesis (e.g., the assembly of 541 or 741), comprising, a first module (e.g., the external component 540) including a functional component (e.g., the processor therein and first structure including magnetic material (e.g., magnet 564, although in other embodiments, the magnetic material is a ferromagnetic material that is not a magnet (e.g., instead a soft magnetic material—more on this below)). The first module is configured to be retained against skin of a recipient via a magnetic field at least partially generated by a permanent magnet implanted in a recipient (e.g., magnet 600) that interacts with the magnetic material of the first structure, the first module including a skin interfacing surface configured to interact with skin of the recipient when the first module is retained against the skin of the recipient. This external component further includes a second module (e.g., module 580 or 780) including a second structure including magnetic material (magnet 582, although in other embodiments, the magnetic material is a ferromagnetic material that is not a magnet (e.g., instead a soft magnetic material—more on this below)) configured to enhance magnetic retention of the external component to skin of a recipient. In some embodiments, the second module is removably attached to the first module and visible from an outside of the external component when the second module is attached to the first module and when viewed from a side opposite the skin interfacing side (e.g., when looking downward along the longitudinal axis 599 in
In an exemplary embodiment, the second module extends about a majority of the first module (in the embodiment of
The ring can include a single annular magnet, can include a plurality of annular magnets, can include a plurality of magnets that are arrayed about the longitudinal axis 599 in a symmetrical manner (while in other embodiments, in a non-symmetrical manner). Any arrangement or configuration of magnet(s) that can enable the teachings detailed herein can be utilized in at least some exemplary embodiments.
Note also that the second module can extend over the first module. Some additional features of such will be described below. However, it is noted that while the embodiment depicted in
In an exemplary embodiment, the thickness (height—distance along the longitudinal axis) of the magnet 564 is no more than about 4, 5, 6, 7, 8, 9, 10, 11 12, 13, 14, 15 mm or any value or range of values therebetween in about 0.1 mm increments. In an exemplary embodiment, the maximum space inside the external component 540, with respect to distance along the longitudinal axis, is about 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 mm or any value or range of values therebetween in about 0.1 mm increments. In an exemplary embodiment, the maximum diameter of magnet 564 is about 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 mm or any value or range of values therebetween in about 0.1 mm increments.
It is also noted that in an exemplary embodiment, an outer circumference of the first sub-component 550 in particular, and the external component 540 in general, has a diameter about 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39 or 40 mm or any value or range of values therebetween in about 0.1 mm increments, and the addition of module 580 increases the respective diameter by 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 3.25, 3.5, 3.75, 4.0, 4.25, 4.5, 4.75, 5, 5.25, 5.5, 5.75, 6.0, 6.25, 6.5, 6.75, 7.0, 7.25, 7.5, 7.75, 8.0, 8.5, 9.0, 9.5, 10, 10.5, 11, 12, 13, 14, 15 mm or more or any value or range of values therebetween in about 0.1 mm increments. Note that these values could be the maximum diameter, the minimum diameter (all on planes normal to the longitudinal axis), a mean diameter, a median diameter and/or a modal diameter.
It is noted that while the embodiments detailed above have been described in terms of an assembly of multiple components (a housing, a magnet, etc.), in an alternate embodiment, a “raw” magnet can extend about the external component 540 without a housing thereabout, perhaps painted or the like.
It is noted that in some embodiments, the module 580 or 780 is such that the permanent magnet thereof, when used with the external component 540, is configured such that the permanent magnet of the module is misaligned with the implanted magnet 600 when the external component interacts with the magnetic field of the implanted magnet. That is, the magnet of the module 580 or 780 does not mirror the implant magnet. Some additional details of this are described below.
Also, as can be seen, the magnets of the modules 580 and 780 are positioned such that the longitudinal axis 599 of the button sound processor does not extend therethrough, but does extend through the magnet of the component 540. In an exemplary embodiment, the magnet of the module is the farthest component of the assembly away from the longitudinal axis, save for a housing containing the magnet (in embodiments that utilize such). In an exemplary embodiment, the longitudinal axis 599 extends through no portion of the module 580 or 780.
In an exemplary embodiment, the increase in retention force by utilizing the oblique angle is increased by about 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 15%, 20%, 25%, 30%, 35%, 40% or more or any value or range of values therebetween in 0.1% increments, all things being equal.
While the embodiment of
Any arrangement that enables the north-south axis of the magnet to be oblique relative to the longitudinal axis 599 can be utilized in at least some exemplary embodiments.
In view of the above, it can be seen that in an exemplary embodiment, there is a body piece configured for transcutaneous communication with an implanted component implanted in a recipient, comprising an inductance coil, a first permanent magnet, and a second permanent magnet. In some embodiments, the first permanent magnet (e.g., magnet 564) has a north-south polarity that is parallel to a longitudinal axis (599) of the body piece. The second permanent magnet (e.g., 882 or 982) has a north-south polarity at an oblique angle relative to the north-south polarity of the first permanent magnet. The body piece is configured such that the second permanent magnet is readily removably connected at least indirectly to the first permanent magnet. In some embodiments, the body piece includes a first housing directly or indirectly supporting the first permanent magnet and directly or indirectly supporting the inductance coil (this is the first sub-component 550, or more accurately, the housing of the first sub-component 550, which supports the permanent magnet and the inductance coil). The body piece includes a second housing containing the second permanent magnet, the second housing being removably connected to the first housing at an outside thereof.
In the embodiment of
In view of
It is briefly noted that while the embodiments detailed above have focused on curved magnets, where the inner circumference of the magnets generally has the same distance from the longitudinal axis 599 with location there about, in some alternate embodiments, the magnets can be bar magnets that are not curved, an example of this is depicted in
Moreover, in an exemplary embodiment, modules 1080 can be utilized that have different size magnets/different magnetic fields generated by the magnets, and a given module can be selected depending on the desired/needed retention force.
It is noted in an at least some exemplary embodiments, crossmember 1090 can be made of a magnetic material that conducts the flux generated by the magnets in a manner different from that which would otherwise be the case if crossmember 1090 was made of a non-magnetic material (e.g., such as plastic). It is noted that in an exemplary embodiment, crossmember 1090 can comprise a housing made of nonmagnetic material in which is housed a component made of magnetic material. In an exemplary embodiment, soft iron is utilized. Any type of material that will channel the magnetic field generated by the magnets can be utilized.
As can be seen in
Thus, in view of the above, with respect to
The embodiment of
Thus, in an exemplary embodiment, there is a module that includes the second structure detailed above, where the second structure is a conductor made of soft magnetic material extending from a first side of the first module to a second side of the first module opposite the first side (as seen in
Note also that in some embodiments, the component that includes magnets 582 (or non-permanent magnet magnetic material—more on this below) is a replacement cover for the first sub-component 550. That is, in an exemplary embodiment, the top of the housing of the first sub-component 550 (e.g., the portion of the housing above seam 505) can be removed and replaced with the module 1080, where structure 1090 is a circular plate that covers the now open housing, thus shielding the internal components in a manner concomitant with the portion of the housing that was removed.
Still further in view of the above, it is again noted that the soft magnetic material can be in the form of a plate extending outboard from the first permanent magnet. In an exemplary embodiment, where the features of the embodiment of
It is noted that in some embodiments, component 1310 can also be a permanent magnet, as is also the case with component 1320. Indeed, in an exemplary embodiment, any structure detailed herein that is disclosed as a magnetic material can be a permanent magnet. It is also noted that in at least some embodiments, any disclosure herein of a permanent magnet constitutes a disclosure of instead a magnetic material that is not a permanent magnet, such as one that conducts magnetic flux, such as a highly permeable soft magnetic material.
In view of the above, it can be seen that in at least some exemplary embodiments, there is a body piece that includes a structure made up of soft magnetic material (entirely or partially) extending between a first permanent magnet and a second permanent magnet (e.g., the crossmember 1090 of
In the embodiment depicted in
Briefly, it is noted that this is an exemplary embodiment where the magnet 1564 is generally unremovable, as opposed to the embodiment of
In an exemplary embodiment, the magnet 1565 adds to the overall magnetic flux generated by the external components, and thus increases the retention force between the external component in the implanted component.
While the embodiment of
It is noted that the concept of attaching a magnet to the top of the external component, whether a magnet is in a modularized form or a simple magnet by itself, can also be applied to the embodiment of
As noted above, in some embodiments, the module that is attached to the external component 540 does not necessarily include a permanent magnet. Instead, in an exemplary embodiment, the application of conductive magnetic material to conduct the flux generated by magnet 564 is the driver for utilizing an additional component with external component 540. To this end,
It is also noted that the embodiments of
In an exemplary embodiment, component 2160 combined with component 2165 channels the magnetic flux generated by the implanted magnet 600 and the magnet 2166 so as to result in a retention force between the external component assembly 2141 and the implanted magnet 600 that is greater than that which would be the case if the component 2064 and/or the component 2165 was replaced with its equivalent weight with permanent magnet(s). In an exemplary embodiment, the increased retention force is more than about 1%, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, or 90% or more, or any value or range of values therebetween in 0.1% increments (e.g., 23.5% to 44.1%, more than 33.3%, etc.).
To be clear, in the exemplary embodiment of
In view of the above, it is to be understood that there are methods associated with the teachings herein. In this regard, by way of example only and not by way of limitation,
Method 2300 further includes method action 2340, which includes attaching the combined first and second portions to a recipient having implanted therein a second permanent magnet such that the first portion and the second portion are magnetically retained to the skin of the recipient via interaction with the magnetic field generated by the second permanent magnet and component(s) of the headpiece (where the components can include a permanent magnet and the second component or a piece of magnetic material that is not a permanent magnet in the second component). In an exemplary embodiment of method 2300, the magnetic material of the second component alters the magnetic flux established by the second permanent magnet such that the magnetic flux is widened about a longitudinal axis between the second permanent magnet and the first portion relative to that which would be the case in the absence of the second portion. In this regard, in an exemplary embodiment, this feature can be achieved via the use of, for example, the module 580 as the second component, which has the magnets 582 outboard of the permanent magnet 564. Such can also be achieved by way of example by the utilization of module 1680 as the second component, which has the magnetic components 1682 outboard of the magnet 564. Note also that in an exemplary embodiment, the second component can be limited to component 1690. That is, the embodiment of
As can be seen in
Method 2600 includes method action 2510, which, as noted above, entails executing method action 2310 and method action 2320. Method 2600 further includes method action 2620, which includes attaching the first portion without the second portion to the recipient by establishing magnetic attraction between the first permanent magnet and the second permanent magnet. In an exemplary embodiment, method action 2620 is executed to evaluate whether or not the first portion (e.g., external component 540 with permanent magnet 564), or more accurately, the magnet thereof, is sufficient to hold the first portion to the recipient, where a determination is made that additional retention force is utilitarian. In an exemplary embodiment, method action 2620 represents the use of the button sound processor for a period of time by the recipient prior to the need for additional retention force (e.g., due to a physiological change of the recipient, due to a change in the habits of the recipient, etc.). Method 2600 further includes method action 2530, which, as noted above, entails executing method action 2330 in method action 2340.
In an exemplary embodiment, method action 2310, the action of obtaining the first portion includes obtaining the first portion with a third portion attached thereto, the third portion being a cover of the headpiece covering a substantial portion of the first portion. In an exemplary embodiment, this can correspond to the housing wall 1148 of
As noted above, in some embodiments, the module 580 or 780 is such that the permanent magnet thereof, when used with the external component 540, is configured such that the permanent magnet of the module is misaligned with the implanted magnet 600 when the external component interacts with the magnetic field of the implanted magnet. That is, the magnet of the module 580 or 780 does not mirror the implant magnet. In some embodiments, the base magnet 564 is angularly symmetric (symmetric about the longitudinal axis 599), and the implant magnet 600 is also angularly symmetric. In such embodiments, the symmetry axis for the implanted and external magnets would align (as shown in the figures—alignment with axis 599). If the module magnet, e.g. 582, is also angular symmetric, the symmetry axis of this magnet would also align with the symmetry axes of the other magnets and the external component 540 would stay on the same spot on the head when the module is attached. However, as noted above, in some exemplary embodiments, the retention module added to the external component 540 may not be angularly symmetric, or, more specifically, the magnet(s) thereof may not be angularly symmetric. For example, such might be the case with respect to a retention module that has an opening, such as that for a battery door or for a cable to another component of the prosthesis or an opening, e.g. to provide access to a battery door.
In some embodiments, the inductance coil of the external component 540 can be moved within the housing thereof to adjust for the fact that this new alignment regime might result in a slight mismatch of the internal and external coils (which might lower transmission efficiency). For example, the coil can be mounted on an internal trolley system, or slidable tray system or the like, so as to move the coil from alignment with the longitudinal axis 599 which is centered about the base magnet 564, to a location offset therefrom.
That said, in an alternate embodiment, the retention module in general, and the magnets thereof and particular, can be configured so as to account for this misalignment when using asymmetrical magnets.
It is noted that consistent with the teachings detailed above, with respect to some of the aforementioned methods, the magnetic material alters the magnetic flux established by the second permanent magnet such that the magnetic flux is concentrated and channeled at an oblique angle away from the longitudinal axis at a skin interfacing location relative to that which would be the case in the absence of the second portion. By skin interfacing location, it is meant the location where the magnetic flux enters (or exits) the skin. It is also noted that in an exemplary embodiment, an increase in retention force between the combined first and second portions and the second permanent magnet above that which is the case between only the first portion and the second permanent magnet is higher than the weight of the second portion. By way of example only and not by way of limitation, if the retention force of the external component 540 to the skin of the recipient is A Newtons without the module 580, and with the module, it is A+B Newtons, B is greater than the weight of module 580. Note that this is just an example to illustrate the concept. It is quite possible that B will be less than the weight of module 580. However, this could be the case (B is greater than the weight of the second portion) with respect to at least some of the embodiments detailed herein (e.g., the embodiment of
The external component can be any of the external components described in U.S. patent application Ser. No. 15/166,628 filed on May 27, 2016, to inventor Tad Jurkiewicz, entitled Magnet Positioning System, as modified if such has utilitarian value to be practiced with the teachings detailed herein. In an exemplary embodiment, the external component's detailed herein and variations thereof have any or all of the features of the external component described in the aforementioned patent application. Accordingly, this application constitutes a disclosure of one or more embodiments where any one or more teachings herein is combined with any one or more teachings in that patent application.
It is briefly noted that in some embodiments that utilize the two modules, the first module includes a first permanent magnet and the second module includes a second permanent magnet, the second permanent magnet being a different configuration than the first permanent magnet. By different configuration, it is meant that, for example, one magnet is a disk magnet, and another magnet is a bar magnet, or one magnet is a disk magnet, and another magnet is a ring magnet, etc. This as opposed to merely a different size.
In an exemplary embodiment, the height of the external component assembly (distance along the longitudinal axis) is no more than 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or 15 cm or any value or range of values therebetween in 0.1 cm increments, and a retention force for a given scenario (e.g., given skin flap thickness and given implanted magnet) can be increased at least about 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 100% or more or any value or range of values therebetween in 0.1% increments, via the addition of the second component, without increasing the height of the external component from that which was the case prior to the increase, all other things being equal. In an exemplary embodiment, the teachings detailed herein are used without the additional module/with the ordinary external component 540, with skin flap thicknesses of less than 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, or 15 mm and the additional module is used/the external component 540 is modified according to the teachings herein for skin values greater than one or more of those values, such as values that are 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75% greater than the baseline skin flap thickness (one of the aforementioned thicknesses).
In an exemplary embodiment, a retention force is increased from about 400 mN to about 700 mN utilizing the second component, or from about 450 mN to about 680 mN, or from about 480 mN to about 680 nM. The increase can be from 200 mN to any value thereabove to about 1.5 mN or any range of values therebetween in 0.1 mN increments.
It is noted that any disclosure of a device and/or system herein corresponds to a disclosure of a method of utilizing such device and/or system. It is further noted that any disclosure of a device and/or system herein corresponds to a disclosure of a method of manufacturing such device and/or system. It is further noted that any disclosure of a method action detailed herein corresponds to a disclosure of a device and/or system for executing that method action/a device and/or system having such functionality corresponding to the method action. It is also noted that any disclosure of a functionality of a device herein corresponds to a method including a method action corresponding to such functionality. Also, any disclosure of any manufacturing methods detailed herein corresponds to a disclosure of a device and/or system resulting from such manufacturing methods and/or a disclosure of a method of utilizing the resulting device and/or system.
In an exemplary embodiment, there is an external component of a prosthesis, comprising: a first module including a functional component and first structure including magnetic material, wherein the first module is configured to be retained against skin of a recipient via a magnetic field at least partially generated by a permanent magnet implanted in a recipient that interacts with the magnetic material of the first structure, the first module including a skin interfacing surface configured to interact with skin of the recipient when the first module is retained against the skin of the recipient; and a second module including a second structure including magnetic material configured to enhance magnetic retention of the external component to skin of a recipient, wherein the second module is removably attached to the first module and visible from an outside of the external component when the second module is attached to the first module and when viewed from a side opposite the skin interfacing side. In an exemplary embodiment, there is an external component of a prosthesis as detailed above and/or below, wherein the first module includes a first permanent magnet and the second module includes a second permanent magnet, the second permanent magnet being a different configuration than the first permanent magnet. In an exemplary embodiment, there is an external component of a prosthesis as detailed above and/or below, wherein the second module includes a second permanent magnet being made at least in part of the magnetic material, wherein the external component is configured such that the second permanent magnet is misaligned with an implanted magnet when the external component interacts with the magnetic field of the implanted magnet.
In an exemplary embodiment, there is a button sound processor, comprising: a first component including a first permanent magnet; and a second component including magnetic material, wherein the second component is configured to direct a magnetic flux at least partially generated by the first permanent magnet differently from that which would exist in the absence of the second component via the soft magnetic material. In an exemplary embodiment, there is a button sound processor as described above and/or below, wherein the magnetic material is in the form of a structure extending outboard from the first permanent magnet. In an exemplary embodiment, there is a button sound processor as described above and/or below, wherein the soft magnetic plate is a cover of the external component facing away from a skin interfacing side of the external component. In an exemplary embodiment, there is a button sound processor as described above and/or below, wherein the second component includes a second permanent magnet; and the longitudinal axis of the button sound processor extends through the first permanent magnet and not the second permanent magnet.
In an exemplary embodiment, there is a body piece configured for transcutaneous communication with an implanted component implanted in a recipient, comprising: an inductance coil; a first permanent magnet; and a second permanent magnet, wherein the first permanent magnet has a north-south polarity that is parallel to a longitudinal axis of the body piece, the second permanent magnet has a north-south polarity at an oblique angle relative to the north-south polarity of the first permanent magnet, and the body piece is configured such that the second permanent magnet is readily removably connected at least indirectly to the first permanent magnet. In an exemplary embodiment, there is a body piece configured for transcutaneous communication with an implanted component implanted in a recipient as described above and/or below wherein the body piece includes a structure made up of soft magnetic material extending between the first permanent magnet and the second permanent magnet. In an exemplary embodiment, there is a body piece configured for transcutaneous communication with an implanted component implanted in a recipient as described above and/or below wherein the portion of the structure between the first permanent magnet and the second permanent magnet being angled relative to the longitudinal axis at an oblique angle. In an exemplary embodiment, there is a body piece configured for transcutaneous communication with an implanted component implanted in a recipient as described above and/or below wherein an angle between (i) the portion of the structure between the first permanent magnet and the second permanent magnet and (ii) the north-south axis of the second permanent magnet is oblique.
Unless otherwise specified or otherwise not enabled by the art, any one or more teachings detailed herein with respect to one embodiment can be combined with one or more teachings of any other teaching detailed herein with respect to other embodiments.
While various embodiments have been described above, it should be understood that they have been presented by way of example only, and not limitation. It will be apparent to persons skilled in the relevant art that various changes in form and detail can be made therein without departing from the spirit and scope of the invention. Thus, the breadth and scope of the present invention should not be limited by any of the above-described exemplary embodiments, but should be defined only in accordance with the following claims and their equivalents.
Number | Name | Date | Kind |
---|---|---|---|
3043000 | Hatfield | Jul 1962 | A |
3487403 | Pihl | Dec 1969 | A |
3573812 | Pihl | Apr 1971 | A |
D227118 | Muraoka | Jun 1973 | S |
3771685 | Micallef | Nov 1973 | A |
3801767 | Marks | Apr 1974 | A |
3987967 | Kuznetsov et al. | Oct 1976 | A |
4003521 | Hess | Jan 1977 | A |
4038990 | Thompson | Aug 1977 | A |
4197840 | Beck et al. | Apr 1980 | A |
4199741 | Paulet | Apr 1980 | A |
4226164 | Carter | Oct 1980 | A |
4240428 | Akhavi | Dec 1980 | A |
4257936 | Matsumoto et al. | Mar 1981 | A |
4317969 | Riegler et al. | Mar 1982 | A |
4352960 | Dormer et al. | Oct 1982 | A |
D267541 | Kanemitsu | Jan 1983 | S |
4414701 | Johnson | Nov 1983 | A |
4596971 | Hirabayashi et al. | Jun 1986 | A |
4606329 | Hough | Aug 1986 | A |
4610621 | Taber et al. | Sep 1986 | A |
4628907 | Epley | Dec 1986 | A |
4634191 | Studer | Jan 1987 | A |
4676772 | Hooven | Jun 1987 | A |
4726378 | Kaplan | Feb 1988 | A |
4731718 | Sheu | Mar 1988 | A |
4736747 | Drake | Apr 1988 | A |
4743264 | Sherva-Parker | May 1988 | A |
4792368 | Sagawa et al. | Dec 1988 | A |
4817607 | Tatge | Apr 1989 | A |
RE32947 | Dormer et al. | Jun 1989 | E |
4868530 | Ahs | Sep 1989 | A |
4917504 | Scott et al. | Apr 1990 | A |
4918745 | Hutchison | Apr 1990 | A |
4920679 | Sarles et al. | May 1990 | A |
5014592 | Zweig et al. | May 1991 | A |
5015224 | Maniglia | May 1991 | A |
5096763 | Ogata et al. | Mar 1992 | A |
5105811 | Kuzma | Apr 1992 | A |
5183056 | Dalen et al. | Feb 1993 | A |
5196710 | Kalfaian | Mar 1993 | A |
5282858 | Bisch et al. | Feb 1994 | A |
5314453 | Jeutter | May 1994 | A |
D348067 | Lucey et al. | Jun 1994 | S |
5338287 | Miller et al. | Aug 1994 | A |
5360388 | Spindel et al. | Nov 1994 | A |
5423317 | Iijima et al. | Jun 1995 | A |
5456654 | Ball | Oct 1995 | A |
5554096 | Ball | Sep 1996 | A |
5603726 | Schulman et al. | Feb 1997 | A |
5624376 | Ball et al. | Apr 1997 | A |
5630835 | Brownlee | May 1997 | A |
5716407 | Knapp et al. | Feb 1998 | A |
5746897 | Heimanson et al. | May 1998 | A |
5749912 | Zhang et al. | May 1998 | A |
5757183 | Smith et al. | May 1998 | A |
5775652 | Crawshaw et al. | Jul 1998 | A |
5785477 | McGuffey et al. | Jul 1998 | A |
5800336 | Ball et al. | Sep 1998 | A |
5857958 | Ball et al. | Jan 1999 | A |
5877664 | Jackson, Jr. | Mar 1999 | A |
5897486 | Ball et al. | Apr 1999 | A |
5913815 | Ball et al. | Jun 1999 | A |
5945762 | Chen et al. | Aug 1999 | A |
5965282 | Baermann | Oct 1999 | A |
5971334 | Crawshaw et al. | Oct 1999 | A |
6040762 | Tompkins | Mar 2000 | A |
6073973 | Boscaljon et al. | Jun 2000 | A |
6101417 | Vogel et al. | Aug 2000 | A |
6138681 | Chen et al. | Oct 2000 | A |
6157278 | Katznelson et al. | Dec 2000 | A |
6157281 | Katznelson et al. | Dec 2000 | A |
6175767 | Doyle, Sr. | Jan 2001 | B1 |
6178079 | Renger | Jan 2001 | B1 |
6178353 | Griffith et al. | Jan 2001 | B1 |
6190305 | Ball et al. | Feb 2001 | B1 |
6208235 | Trontelj | Mar 2001 | B1 |
6208882 | Lenarz et al. | Mar 2001 | B1 |
6217508 | Ball et al. | Apr 2001 | B1 |
6219580 | Faltys et al. | Apr 2001 | B1 |
6244142 | Swanson | Jun 2001 | B1 |
6246533 | Davis et al. | Jun 2001 | B1 |
6259951 | Kuzma et al. | Jul 2001 | B1 |
6263230 | Haynor et al. | Jul 2001 | B1 |
6272382 | Faltys et al. | Aug 2001 | B1 |
6292678 | Hall et al. | Sep 2001 | B1 |
6295472 | Rubinstein et al. | Sep 2001 | B1 |
6295473 | Rosar | Sep 2001 | B1 |
6308101 | Faltys et al. | Oct 2001 | B1 |
6313551 | Hazelton | Nov 2001 | B1 |
6348070 | Teissl et al. | Feb 2002 | B1 |
6355998 | Schöb et al. | Mar 2002 | B1 |
6358281 | Berrang et al. | Mar 2002 | B1 |
6401723 | Garibaldi et al. | Jun 2002 | B1 |
6475134 | Ball et al. | Nov 2002 | B1 |
6505062 | Ritter et al. | Jan 2003 | B1 |
6506987 | Woods | Jan 2003 | B1 |
6522909 | Garibaldi et al. | Feb 2003 | B1 |
6542777 | Griffith et al. | Apr 2003 | B1 |
6571676 | Folsom et al. | Jun 2003 | B1 |
6643378 | Schumaier | Nov 2003 | B2 |
6668065 | Lee et al. | Dec 2003 | B2 |
6838963 | Zimmerling et al. | Jan 2005 | B2 |
6857612 | Goodbred | Feb 2005 | B2 |
D512416 | Malaver | Dec 2005 | S |
6991594 | Holcomb | Jan 2006 | B2 |
7038565 | Chell | May 2006 | B1 |
7091806 | Zimmerling et al. | Aug 2006 | B2 |
7190247 | Zimmerling | Mar 2007 | B2 |
7191007 | Desai et al. | Mar 2007 | B2 |
7200504 | Fister | Apr 2007 | B1 |
7225028 | Della Santina et al. | May 2007 | B2 |
7266208 | Charvin et al. | Sep 2007 | B2 |
7338028 | Zimmerling et al. | Mar 2008 | B2 |
7386143 | Easter et al. | Jun 2008 | B2 |
7532937 | Horio et al. | May 2009 | B2 |
7566296 | Zimmerling et al. | Jul 2009 | B2 |
7610096 | McDonald, III | Oct 2009 | B2 |
7642887 | Zimmerling | Jan 2010 | B2 |
7647120 | Della Santina et al. | Jan 2010 | B2 |
7695427 | Kugler et al. | Apr 2010 | B2 |
7762998 | Birk et al. | Jul 2010 | B2 |
7856986 | Darley | Dec 2010 | B2 |
7976453 | Zimmerling et al. | Jul 2011 | B2 |
7991477 | McDonald, III | Aug 2011 | B2 |
8013699 | Zimmerling | Sep 2011 | B2 |
8118725 | Zimmerling et al. | Feb 2012 | B2 |
8211174 | Park et al. | Jul 2012 | B2 |
8255058 | Gibson et al. | Aug 2012 | B2 |
8260435 | Johnson et al. | Sep 2012 | B2 |
8270647 | Crawford et al. | Sep 2012 | B2 |
8340774 | Hochmair et al. | Dec 2012 | B2 |
8406443 | Westerkull | Mar 2013 | B2 |
8515112 | Crawford et al. | Aug 2013 | B2 |
8532783 | Zimmerling et al. | Sep 2013 | B2 |
8634909 | Zimmerling et al. | Jan 2014 | B2 |
8734475 | Ekvall et al. | May 2014 | B2 |
8744106 | Ball | Jun 2014 | B2 |
8758394 | Zimmerling et al. | Jun 2014 | B2 |
8768480 | Charvin | Jul 2014 | B2 |
8811643 | Crawford et al. | Aug 2014 | B2 |
8897475 | Ball et al. | Nov 2014 | B2 |
8983102 | Crawford et al. | Mar 2015 | B2 |
9002469 | D'Ambrosio | Apr 2015 | B2 |
9014782 | Miyoshi | Apr 2015 | B2 |
9022917 | Kasic et al. | May 2015 | B2 |
9042995 | Dinsmoor et al. | May 2015 | B2 |
RE45701 | Zimmerling et al. | Sep 2015 | E |
9136728 | Dinsmoor et al. | Sep 2015 | B2 |
9144676 | Gibson et al. | Sep 2015 | B2 |
9179228 | Ruppersberg et al. | Nov 2015 | B2 |
9210521 | Kasic et al. | Dec 2015 | B2 |
9258656 | Ruppersberg et al. | Feb 2016 | B2 |
9392384 | Crawford et al. | Jul 2016 | B2 |
9526810 | Ruppersberg | Dec 2016 | B2 |
9627120 | Scott et al. | Apr 2017 | B2 |
9736601 | Kasic et al. | Aug 2017 | B2 |
9739842 | Holm et al. | Aug 2017 | B2 |
9788125 | Ruppersberg et al. | Oct 2017 | B2 |
RE46624 | Zimmerling et al. | Dec 2017 | E |
9872115 | Kennes | Jan 2018 | B2 |
9872993 | Zimmerling | Jan 2018 | B2 |
10405891 | Pool et al. | Sep 2019 | B2 |
20010021805 | Blume et al. | Sep 2001 | A1 |
20020076071 | Single | Jun 2002 | A1 |
20020103430 | Hastings | Aug 2002 | A1 |
20020116033 | Greatbatch et al. | Aug 2002 | A1 |
20020116034 | Miller et al. | Aug 2002 | A1 |
20020120332 | Law et al. | Aug 2002 | A1 |
20030034039 | Schmid et al. | Feb 2003 | A1 |
20030034705 | Hakansson | Feb 2003 | A1 |
20030089933 | Janesky et al. | May 2003 | A1 |
20030120202 | Gordon | Jun 2003 | A1 |
20030139782 | Duncan | Jul 2003 | A1 |
20030161481 | Miller et al. | Aug 2003 | A1 |
20030161482 | Miller et al. | Aug 2003 | A1 |
20030163021 | Miller et al. | Aug 2003 | A1 |
20030163022 | Miller et al. | Aug 2003 | A1 |
20030171787 | Money et al. | Sep 2003 | A1 |
20030171792 | Zarinetchi et al. | Sep 2003 | A1 |
20030181956 | Duncan et al. | Sep 2003 | A1 |
20040012470 | Zimmerling et al. | Jan 2004 | A1 |
20040032962 | Westerkull | Feb 2004 | A1 |
20040136558 | Usuki et al. | Jul 2004 | A1 |
20040147804 | Schneider et al. | Jul 2004 | A1 |
20040148025 | Schneider et al. | Jul 2004 | A1 |
20040260361 | Gibson | Dec 2004 | A1 |
20040260362 | Darley | Dec 2004 | A1 |
20050001703 | Zimmerling | Jan 2005 | A1 |
20050004629 | Gibson et al. | Jan 2005 | A1 |
20050062567 | Zimmerling et al. | Mar 2005 | A1 |
20050070346 | Pan | Mar 2005 | A1 |
20050101830 | Easter et al. | May 2005 | A1 |
20050159791 | Daly et al. | Jul 2005 | A1 |
20050165471 | Wang et al. | Jul 2005 | A1 |
20050171579 | Tasche et al. | Aug 2005 | A1 |
20050197715 | Kugler | Sep 2005 | A1 |
20050216075 | Wang et al. | Sep 2005 | A1 |
20050228214 | Schneider et al. | Oct 2005 | A1 |
20050228215 | Schneider et al. | Oct 2005 | A1 |
20050240098 | Zhong et al. | Oct 2005 | A1 |
20060030905 | Malaver | Feb 2006 | A1 |
20060045298 | Westerkull | Mar 2006 | A1 |
20060056649 | Schumaier | Mar 2006 | A1 |
20060084857 | Massengill et al. | Apr 2006 | A1 |
20060119356 | Rabe et al. | Jun 2006 | A1 |
20060184212 | Faltys et al. | Aug 2006 | A1 |
20060217792 | Hussein et al. | Sep 2006 | A1 |
20060241746 | Shaoulian et al. | Oct 2006 | A1 |
20060244560 | Zimmerling et al. | Nov 2006 | A1 |
20060247488 | Waldmann | Nov 2006 | A1 |
20070053536 | Westerkull | Mar 2007 | A1 |
20070083078 | Easter et al. | Apr 2007 | A1 |
20070100197 | Perkins et al. | May 2007 | A1 |
20070126540 | Zimmerling | Jun 2007 | A1 |
20070170533 | Doogue et al. | Jul 2007 | A1 |
20070208403 | Della Santina et al. | Sep 2007 | A1 |
20080009920 | Gibson et al. | Jan 2008 | A1 |
20080044049 | Ho et al. | Feb 2008 | A1 |
20080071353 | Weber et al. | Mar 2008 | A1 |
20080221641 | Hochmair | Sep 2008 | A1 |
20080293998 | Andrews | Nov 2008 | A1 |
20080304686 | Meskens et al. | Dec 2008 | A1 |
20090030529 | Berrang et al. | Jan 2009 | A1 |
20090043149 | Abel | Feb 2009 | A1 |
20090069869 | Stouffer et al. | Mar 2009 | A1 |
20090138062 | Balslev | May 2009 | A1 |
20090237080 | Kato et al. | Sep 2009 | A1 |
20090248155 | Parker | Oct 2009 | A1 |
20090251264 | Fullerton et al. | Oct 2009 | A1 |
20090281367 | Cho et al. | Nov 2009 | A1 |
20090287036 | Shapiro et al. | Nov 2009 | A1 |
20090287278 | Charvin | Nov 2009 | A1 |
20090295521 | Fullerton et al. | Dec 2009 | A1 |
20100145135 | Ball et al. | Jun 2010 | A1 |
20100219712 | Kogure et al. | Sep 2010 | A1 |
20100237969 | Crawshaw | Sep 2010 | A1 |
20100272299 | Van Schuylenbergh et al. | Oct 2010 | A1 |
20100292759 | Hahn et al. | Nov 2010 | A1 |
20110004278 | Aghassian | Jan 2011 | A1 |
20110022120 | Ball et al. | Jan 2011 | A1 |
20110031839 | Fullerton et al. | Feb 2011 | A1 |
20110054237 | Shapiro et al. | Mar 2011 | A1 |
20110077502 | Rofougaran | Mar 2011 | A1 |
20110106210 | Meskens | May 2011 | A1 |
20110112607 | Zierhofer | May 2011 | A1 |
20110130622 | Iberg | Jun 2011 | A1 |
20110152603 | Perkins et al. | Jun 2011 | A1 |
20110224789 | Griffith | Sep 2011 | A1 |
20110264172 | Zimmerling et al. | Oct 2011 | A1 |
20110268303 | Ahsani | Nov 2011 | A1 |
20110285488 | Scott et al. | Nov 2011 | A1 |
20110291507 | Post | Dec 2011 | A1 |
20110295053 | Ball | Dec 2011 | A1 |
20120022616 | Gamham et al. | Jan 2012 | A1 |
20120029267 | Ball | Feb 2012 | A1 |
20120062992 | Kimoto | Mar 2012 | A1 |
20120078035 | Andersson et al. | Mar 2012 | A1 |
20120080039 | Siegert | Apr 2012 | A1 |
20120088956 | Asnes et al. | Apr 2012 | A1 |
20120095283 | Andersson et al. | Apr 2012 | A1 |
20120104875 | Park | May 2012 | A1 |
20120108887 | Vermeiren | May 2012 | A1 |
20120172659 | Ball et al. | Jul 2012 | A1 |
20120237067 | Asnes | Sep 2012 | A1 |
20120238799 | Ball et al. | Sep 2012 | A1 |
20120262019 | Smith et al. | Oct 2012 | A1 |
20120262020 | Smith et al. | Oct 2012 | A1 |
20120284969 | Fullerton et al. | Nov 2012 | A1 |
20120296155 | Ball | Nov 2012 | A1 |
20120313473 | Chen et al. | Dec 2012 | A1 |
20120319809 | Fullerton | Dec 2012 | A1 |
20120323066 | Cho et al. | Dec 2012 | A1 |
20120330378 | Crawford et al. | Dec 2012 | A1 |
20130004003 | Tada | Jan 2013 | A1 |
20130006044 | Menzl | Jan 2013 | A1 |
20130018218 | Haller et al. | Jan 2013 | A1 |
20130023954 | Meskens | Jan 2013 | A1 |
20130046131 | Ball et al. | Feb 2013 | A1 |
20130046360 | Gibson et al. | Feb 2013 | A1 |
20130053874 | Ekvall et al. | Feb 2013 | A1 |
20130096366 | Bervoets et al. | Apr 2013 | A1 |
20130099703 | Epstein et al. | Apr 2013 | A1 |
20130110198 | Stoffaneller | May 2013 | A1 |
20130114834 | Bern | May 2013 | A1 |
20130165738 | Ball et al. | Jun 2013 | A1 |
20130190552 | Leblans | Jul 2013 | A1 |
20130195304 | Andersson | Aug 2013 | A1 |
20130199031 | Fullerton et al. | Aug 2013 | A1 |
20130202140 | Asnes | Aug 2013 | A1 |
20130207760 | Clarke et al. | Aug 2013 | A1 |
20130214631 | Smith et al. | Aug 2013 | A1 |
20130261701 | Kuratle et al. | Oct 2013 | A1 |
20130268012 | Sison | Oct 2013 | A1 |
20130278254 | Reeder et al. | Oct 2013 | A1 |
20130281764 | Bjorn | Oct 2013 | A1 |
20130289384 | Jenison et al. | Oct 2013 | A1 |
20130305522 | Fullerton et al. | Nov 2013 | A1 |
20140005522 | Zurovcik | Jan 2014 | A1 |
20140012069 | Ball | Jan 2014 | A1 |
20140012070 | Nagl et al. | Jan 2014 | A1 |
20140012071 | Nagl et al. | Jan 2014 | A1 |
20140012349 | Zimmerling | Jan 2014 | A1 |
20140064531 | Andersson et al. | Mar 2014 | A1 |
20140094876 | Wingeier et al. | Apr 2014 | A1 |
20140121447 | Kasic et al. | May 2014 | A1 |
20140121450 | Kasic et al. | May 2014 | A1 |
20140121451 | Kasic et al. | May 2014 | A1 |
20140163308 | Miller et al. | Jun 2014 | A1 |
20140163309 | Bernhard et al. | Jun 2014 | A1 |
20140213139 | Ferguson | Jul 2014 | A1 |
20140257081 | Rapoport | Sep 2014 | A1 |
20140270297 | Gustafsson et al. | Sep 2014 | A1 |
20140275731 | Andersson et al. | Sep 2014 | A1 |
20140275736 | Ruppersberg et al. | Sep 2014 | A1 |
20140292321 | Yamazaki et al. | Oct 2014 | A1 |
20140300437 | Fullerton et al. | Oct 2014 | A1 |
20140302741 | Whittaker | Oct 2014 | A1 |
20140321681 | Ball et al. | Oct 2014 | A1 |
20140336447 | Bjorn | Nov 2014 | A1 |
20140343626 | Thenuwara et al. | Nov 2014 | A1 |
20140364681 | Hillbratt et al. | Dec 2014 | A1 |
20140364682 | Hillbratt et al. | Dec 2014 | A1 |
20140364922 | Garnham et al. | Dec 2014 | A1 |
20150022298 | Fullerton | Jan 2015 | A1 |
20150032186 | Cushing et al. | Jan 2015 | A1 |
20150045607 | Hakansson | Feb 2015 | A1 |
20150045855 | Griffith | Feb 2015 | A1 |
20150087892 | Tourrel et al. | Mar 2015 | A1 |
20150092969 | Meskens et al. | Apr 2015 | A1 |
20150104052 | Gustafsson et al. | Apr 2015 | A1 |
20150117689 | Bergs et al. | Apr 2015 | A1 |
20150156595 | Zhong et al. | Jun 2015 | A1 |
20150157778 | Ishiyama et al. | Jun 2015 | A1 |
20150160426 | Chao et al. | Jun 2015 | A1 |
20150160470 | Terajima | Jun 2015 | A1 |
20150173468 | Stevenson | Jun 2015 | A1 |
20150192432 | Noguchi et al. | Jul 2015 | A1 |
20150201290 | Nikles et al. | Jul 2015 | A1 |
20150215708 | Meskens et al. | Jul 2015 | A1 |
20150265842 | Ridler et al. | Sep 2015 | A1 |
20150281860 | Johansson | Oct 2015 | A1 |
20150312686 | Gustafsson et al. | Oct 2015 | A1 |
20150382114 | Andersson et al. | Dec 2015 | A1 |
20160021470 | Gustafsson | Jan 2016 | A1 |
20160037273 | Gustafsson | Feb 2016 | A1 |
20160058555 | Andersson et al. | Mar 2016 | A1 |
20160100260 | Ruppersberg et al. | Apr 2016 | A1 |
20160112813 | Hillbratt et al. | Apr 2016 | A1 |
20160161288 | Lu | Jun 2016 | A1 |
20160198270 | Nagl et al. | Jul 2016 | A9 |
20160205484 | Nagl et al. | Jul 2016 | A1 |
20160234613 | Westerkull | Aug 2016 | A1 |
20160247616 | Smith et al. | Aug 2016 | A1 |
20160361537 | Leigh et al. | Dec 2016 | A1 |
20160381473 | Gustafsson | Dec 2016 | A1 |
20170078808 | Kennes | Mar 2017 | A1 |
20170111728 | Kim et al. | Apr 2017 | A1 |
20170162311 | Shmbo et al. | Jun 2017 | A1 |
20170216523 | Neftel et al. | Aug 2017 | A1 |
20170251313 | Gustafsson | Aug 2017 | A1 |
20180252228 | Henseler et al. | Sep 2018 | A1 |
20180270591 | Kennes | Sep 2018 | A1 |
20180288538 | Andersson et al. | Oct 2018 | A1 |
20180352349 | Fung et al. | Dec 2018 | A1 |
20180369586 | Lee et al. | Dec 2018 | A1 |
20190076649 | Lee et al. | Mar 2019 | A1 |
20190151653 | Leigh et al. | May 2019 | A1 |
20190215623 | Bodvarsson | Jul 2019 | A1 |
20190239007 | Kennes et al. | Aug 2019 | A1 |
20190293454 | Bidaux et al. | Sep 2019 | A1 |
20200114151 | Smith et al. | Apr 2020 | A1 |
20210106815 | Smith et al. | Apr 2021 | A1 |
20210257139 | Nellessen | Aug 2021 | A1 |
20210316136 | Smith et al. | Oct 2021 | A1 |
Number | Date | Country |
---|---|---|
2009101370 | Mar 2013 | AU |
414579 | Aug 1934 | GB |
2196855 | May 1988 | GB |
2205999 | Dec 1988 | GB |
2266045 | Oct 1993 | GB |
2010075394 | Apr 2010 | JP |
2012191448 | Oct 2012 | JP |
101743793 | May 2013 | KR |
101297828 | Aug 2013 | KR |
101537380 | Jul 2015 | KR |
9716835 | May 1997 | WO |
2007024657 | Mar 2007 | WO |
2015065442 | May 2015 | WO |
2016207856 | Dec 2016 | WO |
2016207860 | Dec 2016 | WO |
2017046650 | Mar 2017 | WO |
2017105511 | Jun 2017 | WO |
Entry |
---|
Daniel Rutter, “Comparison: Lightwave 2000, 3000, 4000, Illuminator and Pocket-Bright, and Petzl Tikka” pp. 1-30, Feb. 14, 2002. http://www.dansdata.com/ledlights7.htm. |
Number | Date | Country | |
---|---|---|---|
20180160241 A1 | Jun 2018 | US |